Softwr

Healthcare · head to head

Meru Health vs Woebot Health

Meru Health logo

Meru Health

Healthcare

Twelve week therapist led mental health programme combining an app, a clinician and HRV biofeedback

From
On request
Rated
-
Woebot Health logo

Woebot Health

Healthcare

Conversational CBT chatbot that withdrew from consumer distribution and now sells only to payers and providers

From
On request
Rated
-

The short version

  • Each has a real cost: Meru Health the programme is twelve weeks and then it ends, which fits an episode of treatment but not a chronic condition needing maintenance, so relapse after week twelve lands on whatever pathway the buyer has funded next, if any.; Woebot Health the company withdrew its consumer app in June 2025 after concluding FDA marketing authorisation was not achievable at acceptable cost, which is a plain signal about both regulatory position and commercial durability.
  • They diverge on capability: Meru Health covers Twelve week structured programme, Woebot Health covers Scripted CBT dialogue.
  • Prices and features above were last checked on 1 September 2026.

Where they differ

Only the attributes on which Meru Health and Woebot Health actually diverge.

Attributes where Meru Health and Woebot Health differ
AttributeMeru HealthWoebot Health
PlatformsWeb, iOS, AndroidiOS, Android, Web

Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated), category (Healthcare).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Meru Health

  • Twelve week structured programme
  • Licensed therapist
  • Psychiatric consultation
  • HRV biofeedback device
  • Daily in app practice
  • Meru Health Advanced
  • Payer contracting
  • Outcome measurement

Only in Woebot Health

  • Scripted CBT dialogue
  • Mood tracking
  • Crisis routing
  • Between-session support
  • Payer deployment
  • Provider copilot positioning
  • Research licensing
  • Population reporting

What people use each for

The jobs each tool is most often brought in to do.

Meru Health

  • A health plan that wants a mental health intervention it can underwrite as a bounded episode rather than an open ended benefitnot Woebot Health
  • An employer whose staff need treatment rather than wellbeing content, with a therapist and a prescriber in one pathwaynot Woebot Health
  • A member who needs medication review alongside therapy, which most app based mental health products cannot providenot Woebot Health
  • A health system seeking to offload moderate depression and anxiety from a psychiatry service with long waitsnot Woebot Health

Woebot Health

  • A health plan wanting a low intensity behavioural health option for members on a waiting list for therapynot Meru Health
  • A provider organisation offering structured between-session CBT practice to patients already in treatmentnot Meru Health
  • A research group running a trial that needs a clinically scripted rather than generative conversational agent for safety reasonsnot Meru Health
  • A payer targeting a specific population such as postpartum members where scripted CBT content already existsnot Meru Health

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Meru Health

  • The programme is twelve weeks and then it ends, which fits an episode of treatment but not a chronic condition needing maintenance, so relapse after week twelve lands on whatever pathway the buyer has funded next, if any.
  • Whether the employer, the health plan or the member pays depends on the contract route, and members frequently do not know which applies to them until they receive a bill or discover they do not.
  • A structured programme demands daily engagement, and members who cannot sustain that get much less than the outcome data implies, because the published results reflect members who completed.
  • The heart rate variability device is a differentiator but also a logistics and support burden, adding shipping, returns and device support to what would otherwise be a software deployment.
  • Meru is small relative to Lyra, Spring Health and the large payer owned behavioural health offerings, so an employer choosing it takes on more vendor concentration risk in a category that has seen frequent consolidation.

Woebot Health

  • The company withdrew its consumer app in June 2025 after concluding FDA marketing authorisation was not achievable at acceptable cost, which is a plain signal about both regulatory position and commercial durability.
  • It is not an FDA cleared treatment for any indication, so it cannot be positioned to members as therapy and cannot substitute for a covered behavioural health benefit.
  • The scripted, non-generative design that makes it safe also makes it feel rigid next to current conversational AI, and engagement drops off quickly once users hit the edges of the script.
  • Published evidence is short-horizon symptom change in selected populations, mostly young adults, with little evidence of durable benefit or effect at whole-population scale.
  • With consumer distribution gone, the remaining business depends on a small number of payer and provider contracts, so a buyer should assume real vendor continuity risk over a multi-year term.

Pricing, plan by plan

Meru Health

On request
  • Meru Health$undefined/year
    • Contracted per completed programme or per member per month depending on buyer type
    • Health plan contracts bill differently from employer contracts
    • Member cost sharing depends on whether access comes via insurance or an employer benefit

Woebot Health

On request
  • Woebot for payers and providers$undefined/year
    • Contracted per member per month or as a population licence
    • Sold to health plans and provider organisations, not to employers or individuals
    • No consumer purchase route since the app closed in June 2025

Which should you pick?

Choose Meru Health if

  • You need twelve week structured programme.
  • You work on Web, iOS, Android.
  • You also want licensed therapist.

Choose Woebot Health if

  • You need scripted cbt dialogue.
  • You work on iOS, Android, Web.
  • You also want mood tracking.

Questions people ask

Is Meru Health or Woebot Health better?
Neither clearly leads. Meru Health starts at On request and Woebot Health at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Meru Health or Woebot Health?
Meru Health starts at On request and Woebot Health at On request.
Does Meru Health or Woebot Health run on more platforms?
Meru Health runs on Web, iOS, Android. Woebot Health runs on iOS, Android, Web.
What is Meru Health best used for?
Meru Health is most often used for a health plan that wants a mental health intervention it can underwrite as a bounded episode rather than an open ended benefit, an employer whose staff need treatment rather than wellbeing content, with a therapist and a prescriber in one pathway, a member who needs medication review alongside therapy, which most app based mental health products cannot provide, a health system seeking to offload moderate depression and anxiety from a psychiatry service with long waits. Of those, a health plan that wants a mental health intervention it can underwrite as a bounded episode rather than an open ended benefit and an employer whose staff need treatment rather than wellbeing content, with a therapist and a prescriber in one pathway are not what Woebot Health is typically brought in for.
What can Meru Health do that Woebot Health cannot?
Meru Health covers Twelve week structured programme, Licensed therapist, Psychiatric consultation, HRV biofeedback device. Woebot Health covers Scripted CBT dialogue, Mood tracking, Crisis routing, Between-session support.

Answered from the vendors’ own pages

Meru Health: Is Meru Health still operating?

Yes. It launched Meru Health Advanced in May 2026 and expanded its Harvard Pilgrim Health Care collaboration in 2025. It has not wound down.

Woebot Health: Is Woebot still available?

Not to consumers. The consumer app closed in June 2025. The company continues to offer the product to payers, providers and researchers.

Meru Health: How long is the programme?

Around twelve weeks. It is a bounded treatment episode rather than open ended therapy, which is why health plans will contract for it.

Woebot Health: Is it FDA cleared?

No. It held Breakthrough Device designation but never obtained marketing authorisation, and the founder cited the cost of that pathway as the reason for closing the consumer app.

Meru Health: Who pays?

It depends on the contract. Meru sells to both health plans and employers, and member cost sharing differs between those routes. Confirm which applies before enrolling.

Woebot Health: Is it generative AI?

Historically no. The dialogue is clinician-written and rule-based, a deliberate safety choice that limits how naturally it converses.

Meru Health: Does it include medication?

Psychiatric consultation is part of the programme where medication is indicated, which distinguishes it from app plus coaching products that cannot prescribe.

Woebot Health: What does the evidence show?

Randomised studies reported reduced depressive symptoms over short periods in selected populations, notably young adults. That is symptom change in a trial, not demonstrated population outcomes.

Share

Related pages

Other head to heads